Mesoblast (MESO) has released an update.
Mesoblast Limited has announced that their Director, Dr. Eric Rose, acquired 21,428 American Depositary Shares (ADS) on the market, valued at US$142,318.35. This transaction has subsequently increased Dr. Rose’s indirect interest in the company, with each ADS representing 10 ordinary shares. Additionally, Dr. Rose is set to receive 5,039,814 ordinary shares, pending shareholder approval at Mesoblast’s 2024 Annual General Meeting.
For further insights into MESO stock, check out TipRanks’ Stock Analysis page.
